产品详情
In vitro | DMSO | Warmed: 53 mg/mL (185.17 mM) | |
Water | Insoluble | ||
Ethanol | 3 mg/mL (10.48 mM) | ||
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 34.94 mL | 174.7 mL | 349.41 mL |
0.5 mM | 6.99 mL | 34.94 mL | 69.88 mL |
1 mM | 3.49 mL | 17.47 mL | 34.94 mL |
5 mM | 0.7 mL | 3.49 mL | 6.99 mL |
*The above data is based on the productmolecular weight 286.2 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10495 |
---|---|
作用机制 | Inhibitor (抑制剂), Agonist (激动剂) |
M. Wt | 286.2 |
Formula | C15H10O6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 520-18-3 |
SMILES | C1=CC(=CC=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)O)O |
产品标签
Product Questions
Product Questions
ZM 306416
ZM 306416 hydrochloride是一种VEGF受体酪氨酸激酶抑制剂,可抑制KDR(IC50 = 100 nM)和Flt(IC50 = 2 uM)酪氨酸激酶…
NVP-BAW2881
NVP-BAW2881是有效的选择性VEGFR抑制剂(血管内皮生长因子受体酪氨酸激酶抑制剂),IC50 为值9 nM,具有抑制…
XL647 (Tesevatinib)
XL647 (Tesevatinib)是一种口服生物可利用的小分子RTK抑制剂,可结合并抑制在肿瘤细胞增殖和肿瘤血管形成中…
Toceranib (PHA 291639, SU 11654)
Toceranib (PHA 291639,SU 11654)是一种激酶抑制剂,通过抑制KIT,血管内皮生长因子受体2和PDGFRβ同时具有抗肿瘤…
Buflomedil HCl
Buflomedil HCl是一种用于治疗外周血管疾病的血管活性剂。